Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

5.93EUR
22 Jul 2019
Change (% chg)

€-0.17 (-2.79%)
Prev Close
€6.10
Open
€6.10
Day's High
€6.16
Day's Low
€5.81
Volume
31,890
Avg. Vol
27,792
52-wk High
€9.86
52-wk Low
€5.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.650
FY 2018 Dec '18 2.18 -1.071
Jun '18 2.27 -1.060
FY 2017 Dec '17 1.58 -1.516
Jun '17 1.79 -1.420
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 2 8.50 13.00 4.00 7.90
Year Ending Dec-20 2 19.00 35.00 3.00 23.38
Earnings (per share)
Year Ending Dec-19 3 -3.16 -2.73 -3.54 -3.05
Year Ending Dec-20 3 -2.79 -2.36 -3.10 -2.40
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 97.98 34.52
P/E High - Last 5 Yrs. -- 169.30 54.21
P/E Low - Last 5 Yrs. -- 53.46 28.29
Beta 1.33 1.29 0.99
Price to Sales (TTM) -- 42.23 7.97
Price to Book (MRQ) -- 12.30 4.45
Price to Tangible Book (MRQ) -- 17.07 5.18
Price to Cash Flow (TTM) -- 64.34 24.33
% Owned Institutions -- 3.23 1.75

Dividends

  Company industry sector
Dividend Yield -- 0.11 1.63
Dividend Yield - 5 Year Avg 0.00 0.05 1.37
Dividend 5 Year Growth Rate -- 0.85 6.83
Payout Ratio(TTM) -- 2.43 47.44

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 67.62 14.69
Sales (TTM) vs TTM 1 Yr. Ago -- 49.06 8.20
Sales - 5 Yr. Growth Rate 19.80 33.40 9.46
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -6.26 18.14
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 22.67 7.10
Capital Spending - 5 Yr. Growth Rate 102.43 26.51 7.89

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.79 2.54
Current Ratio (MRQ) -- 3.88 3.54
LT Debt to Equity (MRQ) -- 7.90 12.58
Total Debt to Equity (MRQ) -- 20.96 17.60
Interest Coverage (TTM) -- 31.43 14.89

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 23.23 50.19
Gross Margin - 5 Yr. Avg. -- 59.05 51.31
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -704.16 -11.70 16.45
Operating Margin (TTM) -- -122.20 -6.60
Operating Margin - 5 Yr. Avg. -718.37 -27.79 11.94
Pre-Tax Margin (TTM) -- -123.99 -6.95
Pre-Tax Margin - 5 Yr. Avg. -695.43 -32.85 15.91
Net Profit Margin (TTM) -- -129.71 -10.73
Net Profit Margin - 5 Yr. Avg. -695.35 -37.76 11.28
Effective Tax Rate (TTM) -- 17.16 20.55
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.50

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 10,321,994 879,617,670
Net Income/Employee (TTM) -- 2,332,961 102,957,990
Receivable Turnover (TTM) -- 12.39 5.90
Inventory Turnover (TTM) -- 2.40 3.64
Asset Turnover (TTM) -- 0.33 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.42 10.25
Return on Assets - 5 Yr. Avg. -27.54 6.15 11.20
Return on Investment (TTM) -- 7.77 12.69
Return on Investment - 5 Yr. Avg. -30.39 8.01 14.18
Return on Equity (TTM) -- 8.27 17.17
Return on Equity - 5 Yr. Avg. -30.96 8.94 15.55
  1 Year 3 Year 5 Year
Sales % 32.19 14.93 19.80
EPS (TTM) % 27.74 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -1.61 -2.04 99 1
13 Week -15.28 -14.85 84 5
26 Week -12.61 -23.25 86 23
52 Week -36.16 -37.71 90 6
YTD -2.40 -16.84 89 7
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.31%
# of Holders: 21
Total Shares Held: 9,024,238
3 Mo. Net Change: 77,252
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 0
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.